How should a benign-appearing hepatic lesion requiring follow-up be described?

How should a benign-appearing hepatic lesion requiring follow-up be described?

• A. Label as likely benign with recommended short-interval follow-up imaging (e.g., MRI with contrast) to confirm stability.
• B. Label as malignant.
• C. No follow-up needed.
• D. Recommend immediate biopsy.

Answer: (A)

When a hepatic lesion looks benign but there is still some uncertainty, the best approach is to describe it as likely benign and recommend short-interval follow-up imaging to confirm stability. This balances prudent management with avoiding unnecessary invasive steps while still actively monitoring for any change that might suggest a different diagnosis. MRI with contrast is often the preferred follow-up modality because it provides detailed tissue characterization and can reliably detect subtle changes in lesion size, enhancement pattern, or other features over time. If the lesion remains stable on follow-up, confidence grows that the lesion is benign. If changes are observed, the imaging result can guide further workup, which might include additional imaging, biopsy, or consultation. Labeling the lesion as malignant would inappropriately escalate the workup and potentially subject the patient to invasive procedures without evidence of cancer. No follow-up misses the opportunity to detect evolution toward malignancy, and immediate biopsy is not warranted when imaging strongly suggests a benign lesion with intent to monitor.

When a hepatic lesion looks benign but there is still some uncertainty, the best approach is to describe it as likely benign and recommend short-interval follow-up imaging to confirm stability. This balances prudent management with avoiding unnecessary invasive steps while still actively monitoring for any change that might suggest a different diagnosis.

MRI with contrast is often the preferred follow-up modality because it provides detailed tissue characterization and can reliably detect subtle changes in lesion size, enhancement pattern, or other features over time. If the lesion remains stable on follow-up, confidence grows that the lesion is benign. If changes are observed, the imaging result can guide further workup, which might include additional imaging, biopsy, or consultation.

Labeling the lesion as malignant would inappropriately escalate the workup and potentially subject the patient to invasive procedures without evidence of cancer. No follow-up misses the opportunity to detect evolution toward malignancy, and immediate biopsy is not warranted when imaging strongly suggests a benign lesion with intent to monitor.